About Impetis Biosciences Limited
Data last updated: 07 March 2026
Impetis Biosciences Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Tata Sons Private Limited. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 29 May 2017, the company has been in operation for over 9 years.
Registered with ROC Mumbai under CIN U74999MH2017PLC295474.
Capital: an authorised share capital of ₹4.9 Cr and a paid-up capital of ₹3.73 Cr. It is led by directors including Abhishek Jain and Kanwar Rameshwar Singh Jamwal.
Last AGM: 24 June 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.61 Cr, a decline of 71% compared to the previous year.
The company has a workforce of approximately 2 employees as per the latest available data. It operates as a subsidiary of Tata Sons Private Limited.
The company is associated with 1 brand - Impetis.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website impetisbiosciences.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address6Th Floor Wing E Times Square, Marol Andheri – Kurla Road Gamdevi Andheri – East, Mumbai, Maharashtra, India – 400059
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Impetis Biosciences Limited
Impetis Biosciences Limited operates one associated brand: Impetis. These brands represent Impetis Biosciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Drug discovery and licensing for auto-immune, inflammatory, and oncology treatments via partnerships. | impetisbiosciences.com |
Competitors & Alternatives of Impetis Biosciences Limited
Brands and companies operating in the same space as Impetis Biosciences Limited include Moderna, argenx, BeiGene and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
mRNA-based therapeutics for diseases including cancer and infections are developed. | Cambridge, United States, United States | 2010 |
|
|
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | Ghent, Belgium, Belgium | 2008 |
|
|
Targeted and immune-oncology drugs for cancer treatment are developed. | Cambridge, United States, United States | 2010 |
|
|
Gene therapies for rare diseases are developed to treat patients. | Columbus, United States, United States | 2020 |
|
|
Developer of antibodies to treat complement-mediated neurodegenerative diseases | San Francisco, United States, United States | 2011 |
|
|
Developer of drugs for treating rare and autoimmune diseases | Dublin, Ireland, Ireland | 2008 |
|
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
|
|
Small molecules are developed for cancer and skin disease treatments. | Wilmington, United States, United States | 1991 |
|
|
ALX Oncology is focused on advancing cancer treatment therapies. | Burlingame, United States, United States | 2015 |
Business Activity of Impetis Biosciences Limited
Impetis Biosciences Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details for Impetis Biosciences Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Impetis Biosciences Limited
Impetis Biosciences Limited is audited by M. A. PARIKH & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M. A. PARIKH & CO. | Locked | Locked | Locked |
Complete auditor history for Impetis Biosciences Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Impetis Biosciences Limited
Impetis Biosciences Limited is currently managed by 3 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Jain | Director | 04 Mar 2024 | 2 Years 4 Months | Current |
|
Kanwar Rameshwar Singh Jamwal
Also directs:
Tata Medical And Diagnostics Limited, Tata Industries Limited, Tata Classedge Limited and 1 more
|
Director | 29 May 2017 | 9 Years 1 Months | Current |
| Tarun Dayal Bhojwani | Director | 16 Jan 2025 | 1 Years 6 Months | Current |
Financials of Impetis Biosciences Limited FY 2025 filings available
Impetis Biosciences Limited reported revenue of ₹1.61 Cr (down 71.00% YoY) for FY 2025.
Ten-year financial statements for Impetis Biosciences Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Impetis Biosciences Limited
Shareholding and ownership data for Impetis Biosciences Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Impetis Biosciences Limited
Impetis Biosciences Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Impetis Biosciences Limited
Impetis Biosciences Limited has a workforce of 2 employees as of Apr 10, 2024.
Employee and EPFO history for Impetis Biosciences Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Impetis Biosciences Limited
GST registrations and filing compliance for Impetis Biosciences Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Impetis Biosciences Limited
Credit ratings, litigation, and regulatory alerts for Impetis Biosciences Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Impetis Biosciences Limited
MSME payment history for Impetis Biosciences Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Impetis Biosciences Limited
Corporate group structure for Impetis Biosciences Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Impetis Biosciences Limited
MCA filings and documents for Impetis Biosciences Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Impetis Biosciences Limited
Frequently Asked Questions about Impetis Biosciences Limited
Impetis Biosciences Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 29 May 2017 (9+ years old) and is registered under CIN U74999MH2017PLC295474. The company has 2 employees.
Impetis Biosciences Limited reported revenue of ₹1.61 Cr for FY 2025 (down 71.00% YoY).
The current directors of Impetis Biosciences Limited are:
- Abhishek Jain - Director
- Kanwar Rameshwar Singh Jamwal - Director
- Tarun Dayal Bhojwani - Director
The primary industry of Impetis Biosciences Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
Impetis Biosciences Limited can be reached at the registered office: 6Th Floor Wing E Times Square, Marol Andheri – Kurla Road Gamdevi Andheri – East, Mumbai, Maharashtra, India – 400059, or through the website impetisbiosciences.com.
The authorised capital is ₹4.9 Cr, and the paid-up capital is ₹3.73 Cr.